tiprankstipranks
Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ:BMRN
US Market
Want to see BMRN full AI Analyst Report?

BioMarin Pharmaceutical (BMRN) Ownership - Who Owns BioMarin Pharmaceutical?

2,443 Followers

BioMarin Pharmaceutical (BMRN) Ownership Overview

0.32%31.87%36.55%20.94%10.31%
36.55% Other Institutional Investors
20.94% ETFs
10.31% Public Companies and
Individual Investors
The ownership structure of BioMarin Pharmaceutical (BMRN) stock is a mix of institutional, retail, and individual investors. Approximately 89.36% of the company’s stock is owned by Institutional Investors, 0.32% is owned by Insiders, and 10.31% is owned by Public Companies and Individual Investors.
The ownership structure of BioMarin Pharmaceutical (BMRN) stock is a mix of institutional, retail, and individual investors. Approximately 68.43% of the company’s stock is owned by Institutional Investors, 0.32% is owned by Insiders, and 20.94% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
May 11, 2026
xxxxxxxxxxxxx
$176682
Mar 12, 2026
xxxxxxxxxxxxx
$996744
Feb 26, 2026
xxxxxxxxxxxxx
$1599103
Feb 26, 2026
xxxxxxxxxxxxx
$381901

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$822593766
Mar 31, 2024
xxxxxxxxxxxxx
$11688402
Mar 31, 2024
xxxxxxxxxxxxx
$398936730
Mar 31, 2024
xxxxxxxxxxxxx
$801819342

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
16,471,832Institution8.52%943,671,255
15,183,140Institution7.86%869,842,091
14,561,759Institution7.53%834,243,173
14,194,005Institution7.34%813,174,546
11,842,220Institution6.13%678,440,784
11,483,325Institution5.94%657,879,689
7,062,077Institution3.65%404,586,391
5,179,450Institution2.68%296,730,691
5,143,616Institution2.66%294,677,761
5,075,885Institution2.63%290,797,452

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
15,183,140Institution7.86%869,842,091
11,483,325Institution5.94%657,879,689
5,179,450Institution2.68%296,730,691
5,143,616Institution2.66%294,677,761
2,576,251Institution1.33%147,593,420
2,415,741Institution1.25%138,397,802
2,152,092Institution1.11%123,293,351
1,941,419Institution1.00%111,223,895
1,159,090Institution0.60%66,404,266
1,118,519Institution0.58%64,079,954

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,496,121Institution3.36%343,514,878
6,122,846Institution3.17%345,879,571
4,440,548Institution2.30%250,846,557
2,487,092Institution1.29%140,495,827
2,148,033Institution1.11%121,342,384
1,554,818Institution0.80%81,752,330
1,439,252Institution0.74%82,454,747
1,416,595Institution0.73%74,909,544
1,395,846Institution0.72%73,812,336
957,649Institution0.50%50,353,184

FAQ

Who Owns Biomarin Pharmaceutical Inc. (BMRN)?
According to the latest TipRanks data, approximately 36.55% of the company's stock is held by institutional investors, 0.32% is held by insiders, and 10.31% is held by retail investors.
    What percentage of Biomarin Pharmaceutical Inc. (BMRN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 36.55% of Biomarin Pharmaceutical Inc. (BMRN) stock is held by institutional investors.
      What percentage of Biomarin Pharmaceutical Inc. (BMRN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 10.31% of Biomarin Pharmaceutical Inc. (BMRN) stock is held by retail investors.
        Who owns the most shares of Biomarin Pharmaceutical Inc. (BMRN)?
        Vanguard owns the most shares of Biomarin Pharmaceutical Inc. (BMRN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.